The PennZone

  • Home
  • Non-profit
  • Education
  • Construction
  • Technology
  • Business
  • Entertainment
  • Legal
  • Marketing

Nattokinase Supplement for Cardiovascular and Circulatory Support
The PennZone/10270754

Trending...
  • STO Foundation Launching June 29, 2026 to Advance the Global Tokenization Industry
  • Allstream Energy Partners Announce Media Partnership with the 2026 EPC Show - The Energy Projects Conference
  • CAPHRA: Australia and Thailand show nicotine prohibition fuels illicit markets
Nattokinase Heart Health Supplement
AgeImmune's Nattokinase is one of the purest professional grade supplement on the market which is beneficial for overall heart health.

NEW YORK - PennZone -- Dr. Kanevsky, D.C. C.F.M.P. introduced a new supplement to AgeImmune's product line
earlier this May 2024.
A new addition to the family is Nattokinase supplement in a form of a vegetable capsule
each containing 2,000FU (fibrin unit) representing a unit of potency, which is equal to
100mg. Dr. Kanevsky is recommending a serving size of 2 capsules. However, if you
are in excellent heart health with no family history of blood clots, 1 capsule is enough as
a preventative measure.
Nattokinase is an enzyme derived from Japanese soybean called Natto via fermentation
process with a bacteria called Bacillus subtilis. Natto has been consumed as a
traditional food in Asia for over 2000 years and is believed to be a significant contributor

More on The PennZone
  • Finland Sets Casino Gambling Risk Limits at 2% of Income, 4 Days, 2 Game Types
  • The Prolific Writer, Producer "Hunter" Is Bringing New Music For Summer Release
  • Millennial Maven Creative Foundation Assists In Bringing Juneteenth to the FIFA World Cup Fan Festival with an Authentically Dallas Lineup
  • Two Florida Family Law Firms Named Among the State's Best Divorce Practices for 2026
  • Tacoma Arts Live And Accelerating Creative Enterprise Present Ace Showace

to the longevity of the Japanese people. Although natto has been consumed in Asia for
thousands of years, the fibrinolytic and antithrombolytic property of Nattokinasae was
only discovered in 1987. Recent studies demonstrated that high natto intake is
associated with decreased risk of cardiovascular disease.
This was a sufficient reason for Dr. Kanevsky to add Nattokinase to his line of products.
There is some early evidence that nattokinase may thin the blood and help break up
blood clots. This might protect against heart disease and conditions caused by blood
clots such as stroke, heart attack, and others.
Other studies show that nattokinase may help lower blood pressure and reduce
inflammation in the body.
Unlike traditional blood thinning medications, nattokinase is a natural, widely available
and inexpensive supplement with minimal to no side effects which makes is very

More on The PennZone
  • George Martinez Launches Community Re-distribution Initiative With Donation to the Gamma Alpha Alpha Chapter of Omega Psi Phi Fraternity, Inc
  • SITE Technologies Releases Industry Research Report Exposing the CapEx Intelligence Gap in Commercial Real Estate
  • A Business Novel About Ambition, Ethics, and the Hidden Realities of International Business
  • Century Fasteners Corp. Exhibiting at 2026 Farnborough International Airshow
  • Compton to host first Juneteenth celebration with We Are Us Festival

attractive to Dr. Kanevsky's patients searching for an all-natural approach to their
health.
Having a large database of functional medicine patients Dr Kanevsky easily analyzed
the frequency of complains of a poor heart health, circulation, blood pressure and came
to a conclusion that Nattokinase will become one of the most popular products for
AgeImmune.
As always encapsulated without harmful excipients such as magnesium stearate, silicon
dioxide or titanium dioxide, AgeImmune's Nattokinase is one of the purest professional
grade supplement on the market.
Nattokinase supplement is derived from soy. Dr. Kanevsky warns that if you are allergic
to soy, you shouldn't be taking Nattokinase. It is currently available for purchase at a
discounted price of 21.99 on AgeImmune's website and on Amazon

Contact
AgeImmine
***@netembark.com


Source: Nattokinase Heart Health Supplement

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • GitKraken Introduces Code Flow, a Framework for Software Development in the Agentic Era
  • Nola Blue Records announces new album from The Anthony Paule Soul Orchestra featuring Willy Jordan
  • RIGHT CARS Announces Landmark African Expansion Through Strategic Collaboration Agreement Across Eight Nations
  • Kyle Schwarber Surprises Local Fan After Heartbreaking Loss
  • Custom Woodworker Launches Updated Website
  • Boston Industrial Solutions' Natron® 717N Series UV LED Ink Receives CPSIA Certification
  • purelyIV Expands Mobile IV Therapy to Jackson, MI and Launches PlaqueX® IV Therapy
  • Leimert Juneteenth Community Celebration Set for Friday, June 19, in Leimert Park Village
  • UK Financial Ltd Publishes Maya Preferred Public Proof Package and CoinMarketCap Supply Verification Evidence
  • Justice Advisory Group Expands Federal Sentencing, Prison Preparation and Reentry Support Services
  • Advancing High-Potential Nevada Critical Minerals Portfolio as Major Drill Program Nears Assay Results: Glenstar Minerals: Stock Symbol: GSTRF
  • Allstream Energy Partners to Host 6th Executive Networking After 2026 Energy Projects Conference
  • CAPHRA: Australia and Thailand show nicotine prohibition fuels illicit markets
  • Custom Disposables - Wholesale Packaging Solutions for restaurants, food chains, and food distributors
  • California Security Glass is an affordable bulletproof glass installation company in LA serving a variety of neighboring cities
  • Allstream Energy Partners Announce Media Partnership with the 2026 EPC Show - The Energy Projects Conference
  • STO Foundation Launching June 29, 2026 to Advance the Global Tokenization Industry
  • West Virginia Leaders Announce Support for Election Integrity Network's Model Election Laws Handbook
  • CCHR Condemns Behavioral Treatment After FDA's Missed Deadline to Ban Shock Device
  • Brilliant Minds to Gather in Fort Worth for National Mensa Event

Popular on PennZone

  • New Home of the Month: Spacious Luxury Meets Modern Design in The Bristol at Heritage at Manalapan - 200
  • Love Must Be the Guide: Live Good Shares a Message of Humanity, Compassion and Hope
  • Kevin Francis Design Introduces CHROMA, a Collection of Saturated Solid Color Wool Rugs
  • Thou Shalt not Commit Adultery Lifetime Movie Discussion
  • Calvetta Phair, CEO America's Workforce Solution, LLC Assessed "Awardable" for Department of War work in the CDAO's Tradewinds Solutions Marketplace
  • Autism Podcast Helps Parents Understand Why Behavior Is Communication, Not Defiance
  • Tennessee Laws Lead with Psychotropic Drug Testing in Mass Shooting Cases and Comprehensive Reporting: CCHR Urges Nationwide Adoption
  • Century Fasteners Corp. Hires Tony Marano as Director of Human Resources
  • Milo3D.ai Launches Free AI 3D Model Generator That Turns Text and Images Into Game-Ready 3D Assets in Seconds
  • Agape Leadership Academy Opens Nationwide Enrollment — State ESA Scholarships Cover Full Tuition for Families in 7 States

Similar on PennZone

  • Healthi Life, Bangkok's Urban Longevity House, Honoured at Asia-Pacific Awards 2025
  • Psychiatric Hospitals Fail to Warn Electroshock Patients of FDA-Cited Risks in Estimated $7 Billion Industry
  • Compton to host first Juneteenth celebration with We Are Us Festival
  • Qscription Technologies Appoints Anurag Velekkatt Sunil Kumar to Drive Enterprise Scale
  • A New Pulse for Cardiac Care in Baltimore: St. Elizabeth Rehab & Nursing Welcomes Dr. Hakim Uqdah and Expands Advanced Heart Program
  • Boston Industrial Solutions' Natron® 717N Series UV LED Ink Receives CPSIA Certification
  • purelyIV Expands Mobile IV Therapy to Jackson, MI and Launches PlaqueX® IV Therapy
  • CAPHRA: Australia and Thailand show nicotine prohibition fuels illicit markets
  • CCHR Condemns Behavioral Treatment After FDA's Missed Deadline to Ban Shock Device
  • Expanding Access to Mental Health Care in Toronto with Dr. Stephen Shainbart
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us